ARC Centre of Excellence in Vision Science, Research School of Biology, College of Medicine, Biology and Environment, Australian National University, Canberra, Australia.
Lancet. 2012 May 5;379(9827):1739-48. doi: 10.1016/S0140-6736(12)60272-4.
Myopia has emerged as a major health issue in east Asia, because of its increasingly high prevalence in the past few decades (now 80-90% in school-leavers), and because of the sight-threatening pathologies associated with high myopia, which now affects 10-20% of those completing secondary schooling in this part of the world. Similar, but less marked, changes are occurring in other parts of the world. The higher prevalence of myopia in east Asian cities seems to be associated with increasing educational pressures, combined with life-style changes, which have reduced the time children spend outside. There are no reported major genes for school myopia, although there are several genes associated with high myopia. Any genetic contribution to ethnic differences may be small. However, to what extent many genes of small effect and gene-environment interactions contribute to variations in school myopia within populations remains to be established. There are promising optical and pharmacological interventions for preventing the development of myopia or slowing its progression, which require further validation, and promising vision-sparing treatments for pathological myopia.
近视已经成为东亚地区的一个主要健康问题,因为在过去几十年中,近视的发病率不断上升(现在的毕业生中有 80-90%近视),而且与高度近视相关的致盲性病理变化也越来越多,目前全球有 10-20%的中学毕业生受到影响。在世界其他地区也发生了类似但程度较轻的变化。东亚城市近视患病率较高,似乎与教育压力不断增加有关,同时生活方式的改变也减少了儿童在户外的时间。目前还没有报道表明存在导致学校近视的主要基因,尽管有几个基因与高度近视有关。遗传对种族差异的影响可能很小。然而,在多大程度上,许多微小效应的基因和基因-环境相互作用对人群中学校近视的变化有贡献,仍有待确定。有一些有前途的光学和药物干预措施可以预防近视的发展或减缓其进展,这些措施需要进一步验证,同时也有一些有前途的治疗病理性近视的方法可以保护视力。
Lancet. 2012-5-5
Asia Pac J Ophthalmol (Phila). 2016
Surv Ophthalmol. 2017-3-28
Prog Retin Eye Res. 2017-9-23
Hong Kong Med J. 2018-12
Clin Exp Optom. 2022-5
Ann Acad Med Singap. 2004-1
Int Ophthalmol. 2014-6
Clin Exp Ophthalmol. 2002-6
Int J Ophthalmol. 2025-9-18
Front Ophthalmol (Lausanne). 2025-8-7
Health Qual Life Outcomes. 2025-8-22